Home/Oncoinvent/Kari Myren

KM

Kari Myren

Chief Medical Officer

Therapeutic Areas

Oncology Radiopharmaceuticals

Oncoinvent Pipeline

Drug	Indication	Phase
Radspherin	Peritoneal Metastases from Ovarian Cancer	Phase 2

Leadership Team at Oncoinvent

Chief Executive Officer

Chief Financial Officer

Chief Operating Officer

Kristine Lofthus

Chief Production Officer

Head of Regulatory Affairs

Anne-Kirsti Aksnes

Chief Clinical Officer

Anne Cecilie Alvik

Head of Quality Assurance / Board Member

Kaja Tunhøvd Johansen

Head of Quality Control

Gillies O’Bryan-Tear

Chairperson of the Board

Ingrid Teigland Akay

View full Oncoinvent profile